Economic Impact of Treatment Sequences for Chronic Lymphocytic Leukemia (CLL) and Budget Impact Analysis of Venetoclax Plus Obinutuzumab Sequences for CLL Patients Not Eligible for Full Dose Fludarabine in France

Fang, HH; Ravonimbola, H; Hazra, NC; Zhou, Z; Manzoor, BS; Levy, V; Ysebaert, L; Kabore, N; Sail, K

BLOOD, 2020; 136 ():